X4 Pharmaceuticals Inc (XFOR) Insider Trading
- $30,000.00
- $2,320,657.85
- Jan. 24, 2025
- Paula Ragan
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 24, 2025 | COO | 22,258 | $0.45 | Sell | $10,016.10 | |
Jan. 24, 2025 | Insider | 29,159 | $0.45 | Sell | $13,121.55 | |
Jan. 24, 2025 | CFO | 74,773 | $0.45 | Sell | $33,647.85 | |
Jan. 24, 2025 | CEO | 76,473 | $0.45 | Sell | $34,412.85 | |
Oct. 15, 2024 | CEO | 31,897 | $0.56 | Sell | $17,862.32 | |
Oct. 7, 2024 | COO | 67,695 | $0.57 | Sell | $38,586.15 | |
Oct. 7, 2024 | CFO | 230,645 | $0.55 | Sell | $126,854.75 | |
Oct. 7, 2024 | Insider | 11,127 | $0.58 | Sell | $6,453.66 | |
Oct. 7, 2024 | CEO | 239,436 | $0.55 | Sell | $131,689.80 | |
March 11, 2024 | Insider | 14,235 | $0.88 | Sell | $12,526.80 | |
March 11, 2024 | CEO | 49,678 | $0.88 | Sell | $43,716.64 | |
March 11, 2024 | CFO | 52,500 | $0.88 | Sell | $46,200.00 | |
March 11, 2024 | COO | 15,409 | $0.88 | Sell | $13,559.92 | |
Feb. 12, 2024 | CEO | 21,695 | $1.01 | Sell | $21,911.95 | |
Feb. 12, 2024 | CFO | 27,721 | $1.01 | Sell | $27,998.21 | |
Feb. 12, 2024 | Insider | 787 | $1.01 | Sell | $794.87 | |
Feb. 12, 2024 | COO | 3,683 | $1.01 | Sell | $3,719.83 | |
Nov. 3, 2023 | CEO | 39,906 | $0.90 | Sell | $35,915.40 | |
Nov. 1, 2023 | COO | 67,695 | $0.73 | Sell | $49,417.35 | |
Nov. 1, 2023 | CEO | 199,531 | $0.73 | Sell | $145,657.63 | |
Nov. 1, 2023 | CFO | 230,645 | $0.73 | Sell | $168,370.85 | |
Nov. 1, 2023 | Insider | 10,257 | $0.73 | Sell | $7,487.61 | |
Sept. 8, 2023 | COO | 2,642 | $1.25 | Sell | $3,302.50 | |
Aug. 18, 2023 | Director | 25,000 | $1.20 | Buy | $30,000.00 | |
Aug. 10, 2023 | Insider | 130,056 | $1.06 | Sell | $137,859.36 | |
June 30, 2023 | COO | 464 | $1.89 | Sell | $876.96 | |
June 30, 2023 | CFO | 2,641 | $1.89 | Sell | $4,991.49 | |
June 23, 2023 | CEO | 6,724 | $1.92 | Sell | $12,910.08 | |
June 23, 2023 | CFO | 5,417 | $1.93 | Sell | $10,454.81 | |
June 23, 2023 | COO | 857 | $1.93 | Sell | $1,654.01 | |
June 15, 2023 | COO | 857 | $2.23 | Sell | $1,911.11 | |
June 15, 2023 | CFO | 5,417 | $2.22 | Sell | $12,025.74 | |
June 15, 2023 | CEO | 6,724 | $2.23 | Sell | $14,994.52 | |
May 31, 2023 | CEO | 6,292 | $1.95 | Sell | $12,269.40 | |
Feb. 13, 2023 | CFO | 27,721 | $0.93 | Sell | $25,780.53 | |
Feb. 13, 2023 | COO | 4,348 | $0.93 | Sell | $4,043.64 | |
Feb. 13, 2023 | Insider | 928 | $0.93 | Sell | $863.04 | |
Feb. 13, 2023 | CEO | 21,695 | $0.93 | Sell | $20,176.35 | |
June 3, 2022 | CEO | 6,292 | $1.21 | Sell | $7,613.32 | |
Aug. 17, 2021 | CFO | 10,832 | $5.10 | Sell | $55,243.20 | |
Aug. 17, 2021 | CEO | 13,448 | $5.10 | Sell | $68,584.80 | |
Aug. 17, 2021 | General Counsel | 8,332 | $5.10 | Sell | $42,493.20 | |
July 15, 2021 | CEO | 13,448 | $5.78 | Sell | $77,729.44 | |
June 30, 2021 | CFO | 2,641 | $6.64 | Sell | $17,536.24 | |
June 24, 2021 | CFO | 5,417 | $7.01 | Sell | $37,973.17 | |
June 24, 2021 | General Counsel | 4,166 | $7.00 | Sell | $29,162.00 | |
June 15, 2021 | CFO | 5,417 | $7.84 | Sell | $42,469.28 | |
June 15, 2021 | General Counsel | 4,166 | $7.84 | Sell | $32,661.44 | |
June 2, 2021 | CEO | 2,400 | $9.50 | Sell | $22,800.00 | |
April 5, 2021 | CEO | 2,400 | $9.17 | Sell | $22,008.00 |
Insiders are both buying and selling X4 Pharmaceuticals Inc stock.
The insider traders at X4 Pharmaceuticals Inc are: Paula Ragan, Mary Dibiase, Adam S Mostafa, Adam S. Mostafa, Mark Baldry, Arthur Taveras, Derek M. Meisner, Derek M Meisner, Michael S Wyzga, Murray Stewart, and Renato Skerlj
The most active insider trader at X4 Pharmaceuticals Inc is Paula Ragan with 30 trades.
Paula Ragan has sold the most X4 Pharmaceuticals Inc stock with a total value of $1,128,662.36.
Michael S Wyzga has bought the most X4 Pharmaceuticals Inc stock with a total value of $60,000.00.
The most recent insider trade for X4 Pharmaceuticals Inc was on Jan. 24, 2025.
The single biggest insider buy for X4 Pharmaceuticals Inc was from Michael S Wyzga with a total value of $30,000.00 on Aug. 18, 2023.
The single biggest insider sell for X4 Pharmaceuticals Inc was from Adam S Mostafa with a total value of $168,370.85 on Nov. 1, 2023.